SBI HEALTHCARE OPPORTUNITIES FUND
SBI Mutual Fund · Sectoral/Thematic · Direct plan, growth option
| Period | Scheme | Category median | Healthcare & pharma median |
|---|---|---|---|
| 1 month | -3.3% | -5.4% | -3.1% |
| 3 months | 2.9% | -2.8% | 3.0% |
| 6 months | 22.1% | 8.9% | 21.7% |
| Year to date | 20.6% | -2.0% | 17.3% |
| 1 year | 20.2% | 1.4% | 17.5% |
| 3 years (CAGR) | 22.8% | 13.0% | 20.8% |
| 5 years (CAGR) | 17.8% | 12.0% | 15.3% |
| 7 years (CAGR) | 26.1% | 17.0% | 24.9% |
| 10 years (CAGR) | 14.6% | 14.6% | 14.7% |
| Since first NAV (CAGR) | 18.0% | – | – |
“Healthcare & pharma” is MFIC's grouping of Sectoral/Thematic schemes by the theme or index in their names, not an AMFI category.
| Measure | Scheme | Category median |
|---|---|---|
| 1Y rolling median | 14.4% | 11.8% |
| 3Y rolling median | 21.0% | 17.5% |
| 3Y rolling worst | -8.9% | 3.0% |
| 3Y periods positive | 81% | 100% |
| 3Y periods ahead of benchmark | 72% | 84% |
| 5Y rolling median | 13.4% | 15.6% |
| 5Y rolling worst | -4.2% | 1.8% |
| 5Y periods ahead of benchmark | 99% | 91% |
Benchmark: Nifty 500 (proxy: Motilal Oswal Nifty 500 Index Fund, price return).
| Measure | Scheme | Category median |
|---|---|---|
| Standard deviation (ann.) | 14.4% | 16.7% |
| Sharpe ratio | 1.25 | 0.42 |
| Sortino ratio | 2.27 | 0.63 |
| Beta | 0.64 | 0.96 |
| Alpha (ann.) | 15.8% | 3.7% |
| Upside capture | 117.42 | 106.94 |
| Downside capture | 48.70 | 95.17 |
| Measure | Scheme | Category median |
|---|---|---|
| Maximum drawdown, full history | −30.5% | −23.1% |
| Maximum drawdown, last 10Y | −26.8% | −38.3% |
| Maximum drawdown, last 5Y | −17.7% | −22.3% |
| Current drawdown | −4.3% | −8.3% |
| Recovery time of worst fall | 91 days | – |
Longer histories include more crises, so compare the 5Y and 10Y figures across schemes of different ages.
| Measure | Scheme | Category median |
|---|---|---|
| Expense ratio (TER), Direct plan | n/a | 1.23% |
| AUM, whole scheme (₹ crore) | 5,870 | 1,272 |
| Riskometer | Very High | – |
TER: AMFI, TER of MF Schemes. AUM and riskometer: AMFI, Fund Performance, 30 Sep 2026.
| Measure | Scheme | Benchmark / category |
|---|---|---|
| Return, 1 year (AMFI) | 21.6% | 16.8% TRI |
| Return, 3 years (AMFI) | 22.9% | 21.3% TRI |
| Return, 5 years (AMFI) | 17.9% | 14.6% TRI |
| Month-ends above category median (3Y CAGR) | 56% | 53% median |
| Month-ends in category top quartile (3Y) | 46% | 24% median |
| 7Y rolling CAGR, median (monthly windows) | 15.1% | 15.2% median |
Official benchmark: BSE Healthcare TRI (total return index, as published by AMFI). Category consistency: last 10 years of month-ends, Sectoral/Thematic Direct plans; how it is calculated.
| Year | Scheme | Nifty 500 proxy | Difference |
|---|---|---|---|
| 2026 YTD | 20.6% | -7.8% | +28.4% |
| 2025 | -2.5% | 7.7% | −10.2% |
| 2024 | 43.7% | 15.6% | +28.1% |
| 2023 | 39.7% | 26.5% | +13.2% |
| 2022 | -5.0% | 3.8% | −8.8% |
| 2021 | 21.5% | 30.6% | −9.2% |
| 2020 | 67.7% | 17.2% | +50.5% |
| 2019 | 0.5% | n/a | – |
| 2018 | -8.8% | n/a | – |
| 2017 | 3.3% | n/a | – |
Benchmark proxy: Motilal Oswal Nifty 500 Index Fund (Direct plan NAV, price return), which carries its own costs. The first year starts from the first 31 December in the scheme's history.
| Period | Invested | Value | XIRR |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,36,244 | 26.0% |
| 3 years | ₹3,60,000 | ₹4,71,877 | 18.4% |
| 5 years | ₹6,00,000 | ₹10,33,129 | 21.9% |
| 10 years | ₹12,00,000 | ₹34,62,224 | 20.1% |
Uses this plan's NAVs; ignores stamp duty, exit loads and taxes. One historical path only — the interactive SIP analyzer shows outcomes across every start date.
| Scheme | Category | Correlation | 3Y CAGR |
|---|---|---|---|
| WhiteOak Capital Pharma and Healthcare Fund | Sectoral/Thematic | 0.98 | n/a |
| Kotak Healthcare Fund | Sectoral/Thematic | 0.97 | n/a |
| ITI Pharma and Healthcare Fund | Sectoral/Thematic | 0.96 | 18.9% |
| HDFC Pharma and Healthcare Fund | Sectoral/Thematic | 0.96 | 30.2% |
| Nippon India Pharma Fund | Sectoral/Thematic | 0.95 | 17.6% |
| Tata India Pharma & Healthcare Fund | Sectoral/Thematic | 0.95 | 18.3% |
- What is the latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND?
- The NAV of the Direct plan (growth option) was ₹584.6184 on 2 Oct 2026, as published by AMFI.
- Which category is SBI HEALTHCARE OPPORTUNITIES FUND in?
- It is classified as Sectoral/Thematic in AMFI's daily NAV file; a Sectoral/Thematic scheme invests at least 80% in one sector or theme. MFIC compares it with 253 Sectoral/Thematic schemes (Direct plans).
- What returns has SBI HEALTHCARE OPPORTUNITIES FUND delivered?
- Over one year the NAV changed by 20.2%. The 3-year CAGR is 22.8% (category median 13.0%) and the 5-year CAGR is 17.8% (category median 12.0%). Returns are after expenses and before tax. Past performance may or may not be sustained in future.
- How consistent have its 3-year returns been?
- Measuring a 3-year CAGR from every business day in its history, the median was 21.0%, the lowest was -8.9%, and 81% of 3-year periods ended with a gain. It was ahead of Nifty 500 (index-fund proxy) in 72% of those periods.
- What was the largest fall in SBI HEALTHCARE OPPORTUNITIES FUND's NAV?
- The largest peak-to-trough fall in its available history was 30.5%; within the last five years it was 17.7% (category median 22.3%).
- How volatile is SBI HEALTHCARE OPPORTUNITIES FUND?
- Its annualised standard deviation of monthly returns over the last 36 months is 14.4%, which is below the Sectoral/Thematic category median of 16.7%.
- What would a monthly SIP in SBI HEALTHCARE OPPORTUNITIES FUND have grown to?
- A SIP of ₹10,000 on the first business day of each month for the last 5 years (60 instalments, ₹6,00,000 invested) would have been worth about ₹10,33,129 on 2 Oct 2026, an annualised return (XIRR) of 21.9%. This uses the Direct plan's NAVs, ignores taxes and exit loads, and past performance may or may not be sustained in future.
- How large is SBI HEALTHCARE OPPORTUNITIES FUND?
- Assets under management of the whole scheme were ₹5,870 crore on 30 Sep 2026, as published by AMFI.
- What is the riskometer level of SBI HEALTHCARE OPPORTUNITIES FUND?
- AMFI lists the scheme's riskometer as “Very High”, and its benchmark's as “Very High”. The riskometer is a label of potential risk set under SEBI rules, not a forecast.
- What is the benchmark of SBI HEALTHCARE OPPORTUNITIES FUND and how has it compared?
- Its official benchmark is the BSE Healthcare TRI. Over 3 years AMFI reports a return of 22.9% for this plan against 21.3% for the benchmark total return index; over 5 years 17.9% against 14.6%. Past performance does not indicate future results.
- How often has SBI HEALTHCARE OPPORTUNITIES FUND beaten its category?
- At 56% of the 120 month-ends compared over the last 10 years, its 3-year return was above the median of Sectoral/Thematic schemes (Direct plans); it was in the top quarter at 46% of them. A typical scheme would show about 50%.
- What is the difference between the Direct and Regular plans?
- Both plans hold the same portfolio; the Regular plan includes distribution costs in its expense ratio. Over one year the Direct plan's NAV changed by 20.2% and the Regular plan's by 19.0%. The Regular plan includes the services of a distributor.
Every Monday: this scheme's NAV, 1-month and 1-year return beside its category median, 3-year CAGR and how far it is below its peak. Add more schemes from their pages or from your MFIC watchlist. Free; unsubscribe from any email.